341 related articles for article (PubMed ID: 34384744)
1. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.
Gámez-Díaz L; Grimbacher B
Biomed J; 2021 Aug; 44(4):400-411. PubMed ID: 34384744
[TBL] [Abstract][Full Text] [Related]
2. Different Apples, Same Tree: Visualizing Current Biological and Clinical Insights into CTLA-4 Insufficiency and LRBA and DEF6 Deficiencies.
Gámez-Díaz L; Seidel MG
Front Pediatr; 2021; 9():662645. PubMed ID: 33996698
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide Responsive Beige-like Anchor Protein Deficiency in a Patient with Autoimmune Lymphoproliferative Syndrome-like Disease Phenotype: A Case Report and Literature Review.
Fetyan S; Sakrani NF; Yassin F; Abdallah MF; Elzein N; Azizi G; ElGhazali G
Iran J Allergy Asthma Immunol; 2022 Apr; 21(2):219-227. PubMed ID: 35490276
[TBL] [Abstract][Full Text] [Related]
4. Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations.
Besnard C; Levy E; Aladjidi N; Stolzenberg MC; Magerus-Chatinet A; Alibeu O; Nitschke P; Blanche S; Hermine O; Jeziorski E; Landman-Parker J; Leverger G; Mahlaoui N; Michel G; Pellier I; Suarez F; Thuret I; de Saint-Basile G; Picard C; Fischer A; Neven B; Rieux-Laucat F; Quartier P;
Clin Immunol; 2018 Mar; 188():52-57. PubMed ID: 29330115
[TBL] [Abstract][Full Text] [Related]
5. Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation.
Burnett DL; Parish IA; Masle-Farquhar E; Brink R; Goodnow CC
Immunol Cell Biol; 2017 Oct; 95(9):775-788. PubMed ID: 28611475
[TBL] [Abstract][Full Text] [Related]
6. A Spectrum of Clinical Findings from ALPS to CVID: Several Novel LRBA Defects.
Cagdas D; Halaçlı SO; Tan Ç; Lo B; Çetinkaya PG; Esenboğa S; Karaatmaca B; Matthews H; Balcı-Hayta B; Arıkoğlu T; Ezgü F; Aladağ E; Saltık-Temizel İN; Demir H; Kuşkonmaz B; Okur V; Gümrük F; Göker H; Çetinkaya D; Boztuğ K; Lenardo M; Sanal Ö; Tezcan İ
J Clin Immunol; 2019 Oct; 39(7):726-738. PubMed ID: 31432443
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation.
Revel-Vilk S; Fischer U; Keller B; Nabhani S; Gámez-Díaz L; Rensing-Ehl A; Gombert M; Hönscheid A; Saleh H; Shaag A; Borkhardt A; Grimbacher B; Warnatz K; Elpeleg O; Stepensky P
Clin Immunol; 2015 Jul; 159(1):84-92. PubMed ID: 25931386
[TBL] [Abstract][Full Text] [Related]
8. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
Front Immunol; 2021; 12():671755. PubMed ID: 34447369
[TBL] [Abstract][Full Text] [Related]
9. Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency.
Catak MC; Akcam B; Bilgic Eltan S; Babayeva R; Karakus IS; Akgun G; Baser D; Bulutoglu A; Bayram F; Kasap N; Kiykim A; Hancioglu G; Kokcu Karadag SI; Kendir Demirkol Y; Ozen S; Cekic S; Ozcan D; Edeer Karaca N; Sasihuseyinoglu AS; Cansever M; Ozek Yucel E; Tamay Z; Altintas DU; Aydogmus C; Celmeli F; Cokugras H; Gulez N; Genel F; Metin A; Guner SN; Kutukculer N; Keles S; Reisli I; Kilic SS; Yildiran A; Karakoc-Aydiner E; Lo B; Ozen A; Baris S
Allergy; 2022 Oct; 77(10):3108-3123. PubMed ID: 35491430
[TBL] [Abstract][Full Text] [Related]
10. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.
Lo B; Zhang K; Lu W; Zheng L; Zhang Q; Kanellopoulou C; Zhang Y; Liu Z; Fritz JM; Marsh R; Husami A; Kissell D; Nortman S; Chaturvedi V; Haines H; Young LR; Mo J; Filipovich AH; Bleesing JJ; Mustillo P; Stephens M; Rueda CM; Chougnet CA; Hoebe K; McElwee J; Hughes JD; Karakoc-Aydiner E; Matthews HF; Price S; Su HC; Rao VK; Lenardo MJ; Jordan MB
Science; 2015 Jul; 349(6246):436-40. PubMed ID: 26206937
[TBL] [Abstract][Full Text] [Related]
11. Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients.
Meshaal S; El Hawary R; Adel R; Abd Elaziz D; Erfan A; Lotfy S; Hafez M; Hassan M; Johnson M; Rojas-Restrepo J; Gamez-Diaz L; Grimbacher B; Shoman W; Abdelmeguid Y; Boutros J; Galal N; El-Guindy N; Elmarsafy A
J Clin Immunol; 2020 Aug; 40(6):820-832. PubMed ID: 32506362
[TBL] [Abstract][Full Text] [Related]
12. Lessons from CTLA-4 deficiency and checkpoint inhibition.
Lo B; Abdel-Motal UM
Curr Opin Immunol; 2017 Dec; 49():14-19. PubMed ID: 28806575
[TBL] [Abstract][Full Text] [Related]
13. CTLA4 Message Reflects Pathway Disruption in Monogenic Disorders and Under Therapeutic Blockade.
Garcia-Perez JE; Baxter RM; Kong DS; Tobin R; McCarter M; Routes JM; Verbsky J; Jordan MB; Dutmer CM; Hsieh EWY
Front Immunol; 2019; 10():998. PubMed ID: 31156616
[TBL] [Abstract][Full Text] [Related]
14. Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS).
Casamayor-Polo L; López-Nevado M; Paz-Artal E; Anel A; Rieux-Laucat F; Allende LM
Crit Rev Clin Lab Sci; 2021 Jun; 58(4):253-274. PubMed ID: 33356695
[TBL] [Abstract][Full Text] [Related]
15. Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations.
Hou TZ; Verma N; Wanders J; Kennedy A; Soskic B; Janman D; Halliday N; Rowshanravan B; Worth A; Qasim W; Baxendale H; Stauss H; Seneviratne S; Neth O; Olbrich P; Hambleton S; Arkwright PD; Burns SO; Walker LS; Sansom DM
Blood; 2017 Mar; 129(11):1458-1468. PubMed ID: 28159733
[TBL] [Abstract][Full Text] [Related]
16. What did we learn from CTLA-4 insufficiency on the human immune system?
Mitsuiki N; Schwab C; Grimbacher B
Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiency.
Krone KA; Winant AJ; Vargas SO; Platt CD; Bartnikas LM; Janssen E; Lillehei C; Lee EY; Fishman MP; Casey A
Pediatr Pulmonol; 2021 Jul; 56(7):2232-2241. PubMed ID: 33710794
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune Lymphoproliferative Syndrome: An Overview.
Matson DR; Yang DT
Arch Pathol Lab Med; 2020 Feb; 144(2):245-251. PubMed ID: 30958694
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
